| 今开:0.0 | 昨收:15.855 |
| 最高:0.0 | 最低:0.0 |
| 涨停价:0.0 | 跌停价:0.0 |
| 总市值:8.586209642E9 |
Mylan(MYL)2020-01-28 02:35
$Mylan(MYL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902219-20-000062 Act: 34 Size: 37 KB 网页链接查看全文
Mylan(MYL)2020-01-25 06:10
$Mylan(MYL)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-20-014312 Act: 34 Size: 16 KB 网页链接查看全文
Mylan(MYL)2020-01-23 05:55
$Mylan(MYL)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-20-012058 Act: 34 Size: 25 KB 网页链接查看全文
诺和诺德就减肥药Ozempic和Wegovy的专利纠纷与迈兰制药达成和解。 诺和诺德就减肥药Ozempic和Wegovy的专利纠纷与迈兰制药达成和解。 网页链接
原标题:迈兰6亿欧元出手收购,全球最大仿制药企却在“沉没”? 近日,全球制药公司迈兰(Mylan N.V.)(NASDAQ:MYL)宣布达成一项协议,以6.419亿欧元的价格收购南非制药公司Aspen Pharmacare在欧洲的血栓相关知识产权和商... 网页链接
$Mylan(MYL)$ 15-15D Suspension of duty to report [Section 13 and 15(d)] Accession Number: 0001193125-20-304601 Act: 34 Size: 13 KB 网页链接
$Mylan(MYL)$ 8-K Current report, items 1.01, 1.02, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, and 9.01 Accession Number: 0001193125-20-298224 Act: 34 Size: 831 KB 网页链接
$Mylan(MYL)$ 内部交易: 2020-11-16,Director,Vollebregt Sjoerd S ,期权,9440普通股, $0.00
$Mylan(MYL)$ 内部交易: 2020-11-16,Director,VANDERVEEN RANDALL L ,期权,9440普通股, $0.00
$Mylan(MYL)$ 内部交易: 2020-11-16,Director,Cindrich Robert J ,期权,9440普通股, $0.00
$Mylan(MYL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-031519 Size: 45 KB 网页链接
$Mylan(MYL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-031511 Size: 51 KB 网页链接
$Mylan(MYL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-031512 Size: 25 KB 网页链接
$Mylan(MYL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-031513 Size: 25 KB 网页链接
$Mylan(MYL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-031514 Size: 26 KB 网页链接